• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺瘤-癌序列的病理学:从异常隐窝病灶到浸润性癌。

Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma.

作者信息

Cummings O W

机构信息

Department of Pathology, Indiana University School of Medicine, Indianapolis, USA.

出版信息

Semin Gastrointest Dis. 2000 Oct;11(4):229-37.

PMID:11057950
Abstract

The adenoma-carcinoma sequence postulates that colorectal carcinomas arise from precursor lesions, called adenomas. All adenomas contain dysplastic epithelium that arises from mutations in either the adenomatous polyposis coli gene or DNA mismatch repair genes. The earliest lesion detected with dysplasia is the aberrant crypt focus. Over time, as this lesion acquires additional mutations, it evolves into a classic adenomatous polyp. Adenomatous polyps are classified as tubular, tubulovillous, or villous. Generally, as polyps increase in size, the degree of dysplasia worsens, the villous component increases, the number of genetic abnormalities increases, and the likelihood of harboring invasive carcinoma increases. Carcinomas associated with DNA mismatch repair mutations are more likely to be poorly differentiated and incite a host lymphocytic response. These tumors seem to have a better prognosis, stage for stage, than typical colorectal carcinomas.

摘要

腺瘤-癌序列假说认为,结直肠癌起源于称为腺瘤的前驱病变。所有腺瘤都含有发育异常的上皮,其由腺瘤性息肉病 coli 基因或 DNA 错配修复基因的突变产生。最早检测到发育异常的病变是异常隐窝灶。随着时间的推移,随着该病变获得更多突变,它会演变成典型的腺瘤性息肉。腺瘤性息肉分为管状、管状绒毛状或绒毛状。一般来说,随着息肉大小增加,发育异常程度加重,绒毛成分增加,基因异常数量增加,发生浸润性癌的可能性增加。与 DNA 错配修复突变相关的癌更可能分化不良并引发宿主淋巴细胞反应。这些肿瘤似乎在各分期中比典型结直肠癌预后更好。

相似文献

1
Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma.腺瘤-癌序列的病理学:从异常隐窝病灶到浸润性癌。
Semin Gastrointest Dis. 2000 Oct;11(4):229-37.
2
Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.在家族性腺瘤性息肉病和非家族性腺瘤性息肉病患者中,与结直肠腺瘤向早期癌转变相关的两个p53等位基因的遗传变化。
Cancer Res. 1992 Jul 15;52(14):3965-71.
3
Genetic heterogeneity in sporadic colorectal adenomas.散发性结直肠腺瘤中的基因异质性。
J Pathol. 1997 Mar;181(3):281-6. doi: 10.1002/(SICI)1096-9896(199703)181:3<281::AID-PATH777>3.0.CO;2-M.
4
Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas.MYH 息肉病性结直肠腺瘤中 k-ras G12C 突变频率增加。
Br J Cancer. 2004 Apr 19;90(8):1591-3. doi: 10.1038/sj.bjc.6601747.
5
Clonality of dysplastic epithelium in colorectal adenomas from familial adenomatous polyposis patients.家族性腺瘤性息肉病患者结直肠腺瘤发育异常上皮的克隆性
Cancer Res. 1997 Feb 1;57(3):355-61.
6
[Colorectal serrated adenoma: diagnostic criteria and clinical implications].[结直肠锯齿状腺瘤:诊断标准及临床意义]
Verh Dtsch Ges Pathol. 2007;91:119-25.
7
The colorectal adenoma-carcinoma sequence.结直肠腺瘤-癌序列。
Br J Surg. 2002 Jul;89(7):845-60. doi: 10.1046/j.1365-2168.2002.02120.x.
8
Aberrant crypt foci: what we know and what we need to know.异常隐窝灶:我们所知道的和我们需要知道的。
Clin Gastroenterol Hepatol. 2007 May;5(5):526-33. doi: 10.1016/j.cgh.2007.02.014. Epub 2007 Apr 12.
9
Adenoma-carcinoma sequence of colorectum. Prevalence of K-ras gene mutation in adenomas with increasing degree of dysplasia and aneuploidy.结直肠癌的腺瘤-癌序列。发育异常和非整倍体程度增加的腺瘤中K-ras基因突变的发生率。
Diagn Mol Pathol. 1995 Sep;4(3):198-202.
10
Update on the serrated pathway to colorectal carcinoma.结直肠肿瘤锯齿状途径研究进展。
Hum Pathol. 2011 Jan;42(1):1-10. doi: 10.1016/j.humpath.2010.06.002. Epub 2010 Sep 24.

引用本文的文献

1
Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.结直肠癌循环标志物的发现和应用中的基因组和转录组研究。
Int J Mol Sci. 2023 Aug 3;24(15):12407. doi: 10.3390/ijms241512407.
2
Reelin Protects against Colon Pathology via p53 and May Be a Biomarker for Colon Cancer Progression.Reelin通过p53保护结肠免受病变,可能是结肠癌进展的生物标志物。
Biology (Basel). 2022 Sep 26;11(10):1406. doi: 10.3390/biology11101406.
3
Genetic and epigenetic dependencies in colorectal cancer development.
结直肠癌发生中的遗传和表观遗传依赖性。
Gastroenterol Rep (Oxf). 2022 Aug 12;10:goac035. doi: 10.1093/gastro/goac035. eCollection 2022.
4
Circ_0006174 Accelerates Colorectal Cancer Progression Through Regulating miR-138-5p/MACC1 Axis.Circ_0006174通过调控miR-138-5p/MACC1轴促进结直肠癌进展。
Cancer Manag Res. 2021 Feb 18;13:1673-1686. doi: 10.2147/CMAR.S295833. eCollection 2021.
5
Circ_0067835 Knockdown Enhances the Radiosensitivity of Colorectal Cancer by miR-296-5p/IGF1R Axis.Circ_0067835敲低通过miR-296-5p/IGF1R轴增强结直肠癌的放射敏感性。
Onco Targets Ther. 2021 Jan 18;14:491-502. doi: 10.2147/OTT.S281011. eCollection 2021.
6
Patients with Non-Hodgkin's Lymphoma Are at Risk of Adenomatous Colon Polyps.非霍奇金淋巴瘤患者存在结直肠腺瘤息肉风险。
Dig Dis Sci. 2019 Oct;64(10):2965-2971. doi: 10.1007/s10620-019-05629-z. Epub 2019 May 3.
7
Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma-A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis.结直肠癌化疗耐药机制的研究进展——上皮间质转化、自噬和细胞凋亡的作用。
Cells. 2019 Mar 12;8(3):234. doi: 10.3390/cells8030234.
8
RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer.视黄醇结合蛋白4(RBP4)和血小板反应蛋白2(THBS2)是用于诊断结直肠癌的血清生物标志物。
Oncotarget. 2017 Sep 21;8(54):92254-92264. doi: 10.18632/oncotarget.21173. eCollection 2017 Nov 3.
9
Improved survival of patients with colon cancer detected by screening colonoscopy.通过筛查结肠镜检查发现的结肠癌患者生存率提高。
Int J Colorectal Dis. 2016 May;31(5):1039-1045. doi: 10.1007/s00384-015-2501-6. Epub 2016 Jan 14.
10
Effect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.APE1基因T2197G(Asp148Glu)多态性对结直肠癌患者中APE1、XRCC1、PARP1和OGG1表达的影响。
Int J Mol Sci. 2014 Sep 29;15(10):17333-43. doi: 10.3390/ijms151017333.